153 related articles for article (PubMed ID: 28276714)
1. Diagnostic significance of serum concentrations of soluble Fas ligand (sFasL) in children with autoimmune thyroid disease.
Mikos H; Mikos M; Niedziela M
Autoimmunity; 2017 May; 50(3):192-198. PubMed ID: 28276714
[TBL] [Abstract][Full Text] [Related]
2. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers.
Myśliwiec J; Okota M; Nikołajuk A; Górska M
Adv Med Sci; 2006; 51():119-22. PubMed ID: 17357290
[TBL] [Abstract][Full Text] [Related]
3. Serum concentration of soluble Fas in patients with autoimmune thyroid diseases.
Shimaoka Y; Hidaka Y; Okumura M; Takeoka K; Tada H; Amino N
Thyroid; 1998 Jan; 8(1):43-7. PubMed ID: 9492152
[TBL] [Abstract][Full Text] [Related]
4. Circulating soluble Fas ligand correlates with disease activity in Graves' hyperthyroidism.
Wang CY; Zhong WB; Chang TC; Tsai YF
Metabolism; 2002 Jun; 51(6):769-73. PubMed ID: 12037733
[TBL] [Abstract][Full Text] [Related]
5. Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases.
Mariotti S; Caturegli P; Barbesino G; Marinò M; Del Prete GF; Chiovato L; Tonacchera M; De Carli M; Pinchera A
Clin Endocrinol (Oxf); 1992 Nov; 37(5):415-22. PubMed ID: 1486691
[TBL] [Abstract][Full Text] [Related]
6. Influence of levothyroxine treatment on serum levels of soluble Fas (CD95) and Fas Ligand (CD95L) in chronic autoimmune hypothyroidism.
Nabipour I; Kalantarhormozi M; Assadi M; Jafari SM; Gharibi M; Ahmadi E; Sanjdideh Z
Endocrine; 2010 Dec; 38(3):406-11. PubMed ID: 21042884
[TBL] [Abstract][Full Text] [Related]
7. IDDM and autoimmune thyroid disease in the pediatric age group.
Lorini R; d'Annunzio G; Vitali L; Scaramuzza A
J Pediatr Endocrinol Metab; 1996 Mar; 9 Suppl 1():89-94. PubMed ID: 8887158
[TBL] [Abstract][Full Text] [Related]
8. [Thyroid function tests].
Uchimura H
Rinsho Byori; 2001 Apr; 49(4):319-24. PubMed ID: 11391943
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of serum levels of ghrelin and obestatin in children and adolescents with autoimmune thyroid diseases].
Sawicka B; Bossowski A; Urban M; Szalecki M; Wysocka J; Koput A; Zelazowska-Rutkowska B; Tobolczyk J; Skrzydło M; Rogowski F; Luba M
Pediatr Endocrinol Diabetes Metab; 2009; 15(1):20-7. PubMed ID: 19454185
[TBL] [Abstract][Full Text] [Related]
10. Bispecific thyroglobulin and thyroperoxidase autoantibodies in patients with various thyroid and autoimmune diseases.
Ruf J; Feldt-Rasmussen U; Hegedüs L; Ferrand M; Carayon P
J Clin Endocrinol Metab; 1994 Nov; 79(5):1404-9. PubMed ID: 7962336
[TBL] [Abstract][Full Text] [Related]
11. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
Hu YM; Liu W; Lu GH
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
[TBL] [Abstract][Full Text] [Related]
12. Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases.
Sawicka B; Bossowski A; Szalecki M; Wysoka J; Koput A; Zelazowska-Rutkowska B; Tobolczyk J; Rogowski F; Łuba M
J Pediatr Endocrinol Metab; 2010 Apr; 23(4):345-54. PubMed ID: 20583539
[TBL] [Abstract][Full Text] [Related]
13. [Increased serum soluble Fas ligand in hyperthyroid Graves' disease].
Takeda K; Ohara E; Kaneda T; Hashimoto K; Sasaki M
Rinsho Byori; 1999 Oct; 47(10):961-5. PubMed ID: 10590671
[TBL] [Abstract][Full Text] [Related]
14. The clinical role of serum concentrations of selected cytokines: IL-1β, TNF-α and IL-6 in diagnosis of autoimmune thyroid disease (AITD) in children.
Mikos H; Mikos M; Rabska-Pietrzak B; Niedziela M
Autoimmunity; 2014 Nov; 47(7):466-72. PubMed ID: 24801540
[TBL] [Abstract][Full Text] [Related]
15. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
[TBL] [Abstract][Full Text] [Related]
16. Analysis of diabetes-associated autoantibodies in children and adolescents with autoimmune thyroid diseases.
Rydzewska M; Michalak J; Bossowska A; Chen S; Black S; Powell M; Furmaniak J; Rees Smith B; Bossowski A
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):355-361. PubMed ID: 30903759
[TBL] [Abstract][Full Text] [Related]
17. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
18. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto's disease, Graves' disease and a follow-up study on postpartum thyroid disease.
Gilmour J; Brownlee Y; Foster P; Geekie C; Kelly P; Robertson S; Wade E; Braun HB; Staub U; Michel G; Lazarus JH; Parkes AB
Clin Lab; 2000; 46(1-2):57-61. PubMed ID: 10745983
[TBL] [Abstract][Full Text] [Related]
19. Comparison of autoantibodies level in thyroid autoimmune diseases estimated by different methods.
Gardas A; Blottner A; Domek H
Exp Clin Endocrinol; 1988 Sep; 92(1):77-84. PubMed ID: 3229451
[TBL] [Abstract][Full Text] [Related]
20. Circulating nuclear matrix protein in Graves' disease.
Hara H; Morita Y; Sato R; Ban Y
Endocr J; 2002 Jun; 49(3):343-7. PubMed ID: 12201219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
